Unverified50% confidenceFactExact time

2023年lecanemab（乐卡奈单抗）成为首个在临床试验中被证实可减缓AD认知衰退的抗Aβ抗体，但效果有限且存在脑水肿等副作用风险

1

Sources

50%

Confidence

Long-term

Relevance

7/6/2026

First Seen

Sources

Can a Nasal Spray Reverse Brain Aging? A Deep Dive into the Latest Neuroscience Breakthrough

hackernewshackernews7/4/2026

Related Claims

UnverifiedThe senolytic drug combination dasatinib + quercetin (D+Q) has entered multiple clinical trials targeting neurodegenerative diseases, aimed at selectively eliminating senescent astrocytes and microglia in the brain.57% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/115240

API

curl https://kongchang.com/api/v1/knowledge/claims/115240

MCP

get_claim(id=115240)